NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Maverick0408, you may want to go back and take a look at my NWBO valuation analysis below. It is based on 1.6 billion shares outstanding, and also DCVax-L eventually being approved on a tissue agnostic basis. Currently, there are only about 1.1 billion NWBO shares outstanding. So, my analysis allow for an additional 400,000,000 common shares to be issued and outstanding.

However, even before DCVax-L is approved on a tissue agnostic basis, and just considering newly diagnosed and recurrent Glioblastoma patients, in the US, Canada, UK, Germany and the rest of the EU, and then the rest of the world, according to my analysis, NWBO common shares are valued at $45.16 per share.

For me personally, I will wait for tissue agnostic approvals for both DCVax-L and DCVax Direct. This may take several more years from now, but I do not see a better alternative investment option that currently offers a better upside rate of return, that NWBO.

Based on my analysis, once DCVax-L is approved on a tissue agnostic basis, to treat all or most solid tumor cancers, then we will be looking at trillion dollars valuations, and a per share value of $686 to $1,084 per share, based on 1.6 billion shares outstanding.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172073359